Delivery Order SPE2DB22D1106-SPE2DB25FEMF2
Award Date
5/6/25
Potential Completion Date
5/7/25
Potential Value
$8.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $10,061.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of M-M-R II (measles, mumps, and rubella) vaccine vials. It is a firm-fixed-price delivery order with a completion date of February 3, 2025. The contract was not set aside for any specific business category. In addition to this contract, AmerisourceBergen holds a...
This federal contract award, valued at $4,874.23, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of M-M-R II Vaccine Vials, a vaccine used for the prevention of measles, mumps, and rubella. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999...
This federal contract award, valued at $16,796.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of M-M-R II Vaccine Vials, a critical medical commodity used for infectious disease prevention. This contract is a Delivery Order awarded under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running...
This federal contract award is for the delivery of M-M-R II (measles, mumps, and rubella) vaccine vials to the Defense Logistics Agency (DLA), a Department of Defense (DoD) agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $3,958.67 and is a firm fixed-price delivery order that runs through June 21, 2024. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $1,537.14, is for the delivery of M-M-R II vaccine vials. This is a firm fixed-price delivery order contract with a completion date of May 21, 2024. The contract does not have a set-aside designation. Additionally, Amerisourcebergen Drug Corp holds a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of M-M-R II (Measles, Mumps, and Rubella) vaccine vials. The contract has a ceiling value of $10,496.40 and a completion date of September 20, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen is the prime contractor for this delivery order, which is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a major pharmaceutical sourcing and distribution services company. The $8,683.06 firm fixed price delivery order is for the supply of M-M-R II vaccine vials. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to...
This federal contract award, valued at $49,850.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 2, 2025. The contract is for the delivery of M-M-R II vaccine vials, with a completion date of January 3, 2025. This contract is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and holds a significant Indefinite...
This federal contract award is for the delivery of M-M-R II (measles, mumps, and rubella) vaccine vials to the Defense Logistics Agency (DLA). The $1,661.67 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 24, 2025 with an ultimate completion date of February 25, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $3,148.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of M-M-R II vaccine vials, with a completion date of September 5, 2024. The contract type is a Delivery Order, using a Firm Fixed Price pricing mechanism. There was no set-aside designation for this award. Amerisourcebergen holds significant Indefinite Delivery...